Sulkowski, M.S., Poordad, F., Manns, M.P., Bronowicki, J.P., Rajender Reddy, K., Harrison, S.A., et al. (2013). Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial. HEPATOLOGY, 57, 974-984.

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial.

CRAXI, Antonio;
2013-01-01

2013
Sulkowski, M.S., Poordad, F., Manns, M.P., Bronowicki, J.P., Rajender Reddy, K., Harrison, S.A., et al. (2013). Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial. HEPATOLOGY, 57, 974-984.
File in questo prodotto:
File Dimensione Formato  
26096_ftp.pdf

accesso aperto

Dimensione 1.38 MB
Formato Adobe PDF
1.38 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/73538
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 69
  • ???jsp.display-item.citation.isi??? ND
social impact